Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
As barely a third of European countries meet targets to track concerning Covid-19 variants, diagnostics…
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs…
The Covid-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be a powerful…
The first generation of vaccines for Covid-19 is rolling out all over the world. But…
As AstraZeneca and the University of Oxford’s Covid-19 vaccine debuts in the EU market this…
DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions…
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
The global Covid-19 pandemic has forced us to put our lives on hold, and a…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
Companies developing vaccines, drugs, and diagnostics for Covid-19 are being forced to scale up manufacturing…